Q

uniQure NV
D

QURE

17.050
USD
1.55
(10.00%)
Market Closed
Volume
68,566
EPS
-4
Div Yield
-
P/E
-3
Market Cap
831,070,537
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    N
    NTLA
    0.120
    (0.99%)
    12.190 USD
    S
    SGMO
    0.17500
    (7.56%)
    2.49000 USD
    S
    SLDB
    0.14500
    (3.62%)
    4.15000 USD
    V
    VYGR
    0.06000
    (1.05%)
    5.76000 USD
    More
News

Title: uniQure NV

Sector: Healthcare
Industry: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.